Swedish Orphan Biovitrum AB (publ)

OTC:BIOVF

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BIOVF's stock price target?

Price Target

32.83 USD

According to Wall Street analysts, the average 1-year price target for BIOVF is 32.83 USD with a low forecast of 27.85 USD and a high forecast of 43.17 USD.

What is Swedish Orphan Biovitrum AB (publ)'s Revenue forecast?

Projected CAGR

12%

For the last 8 years the compound annual growth rate for Swedish Orphan Biovitrum AB (publ)'s revenue is 27%. The projected CAGR for the next 3 years is 12%.

What is Swedish Orphan Biovitrum AB (publ)'s Operating Income forecast?

Projected CAGR

26%

For the last 8 years the compound annual growth rate for Swedish Orphan Biovitrum AB (publ)'s operating income is 54%. The projected CAGR for the next 3 years is 26%.

What is Swedish Orphan Biovitrum AB (publ)'s Net Income forecast?

Projected CAGR

44%

For the last 8 years the compound annual growth rate for Swedish Orphan Biovitrum AB (publ)'s net income is 57%. The projected CAGR for the next 3 years is 44%.